GRM5 and prion disease: Since mGluR5 showed a key role in the transmission of toxic signalling also in prion diseases, the same group tested whether mGluR5 knock-out mice would be susceptible to prion infection, observing mild, but significant, effects on disease progression (i.e. delay in disease onset), without affecting survival of infected mice [109].